[Comments on recent guidelines for the treatment of tuberculosis by the American Thoracic Society, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America].
Caminero Luna
J A
JA
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D003906:Developing Countries; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D017410:Practice Guidelines as Topic; D012955:Societies, Medical / Q000592:standards; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents
Comentarios a la reciente normativa de tratamiento de la tuberculosis de la ATS/CDC/IDS.